PMC4564609_01
Endoglin, sflt-1, and plgf levels measured throughout pregnancy.
CRIOG2015-123408.001.jpg
PMC4564609_01_CRIOG2015-123408.001.jpg
fig1
Endoglin measurements showed a decreasing trend over time, with a nadir (16.88 ng/mL before plasmapheresis and 9.45 ng/mL after plasmapheresis) at 20 + 5 weeks of gestation (Figure 1). sflt-1 levels measured before plasmapheresis as well one day after plasmapheresis showed a decreasing trend until the fifth course (24 + 5 weeks of gestation) (Figure 2). plgf immediately after plasmapheresis showed an increasing trend throughout gestation.
sflt-1, measured immediately before and after treatment and at the following day.
CRIOG2015-123408.002.jpg
PMC4564609_01_CRIOG2015-123408.002.jpg
fig2
Endoglin measurements showed a decreasing trend over time, with a nadir (16.88 ng/mL before plasmapheresis and 9.45 ng/mL after plasmapheresis) at 20 + 5 weeks of gestation (Figure 1). sflt-1 levels measured before plasmapheresis as well one day after plasmapheresis showed a decreasing trend until the fifth course (24 + 5 weeks of gestation) (Figure 2). plgf immediately after plasmapheresis showed an increasing trend throughout gestation.
plgf, measured immediately before and after treatment and at the following day.
CRIOG2015-123408.003.jpg
PMC4564609_01_CRIOG2015-123408.003.jpg
fig3
The measurements before plasmapheresis as well as at the following day showed a similar trend (Figure 3).